290 related articles for article (PubMed ID: 24177032)
1. Cholecystokinin and pancreatic cancer: the chicken or the egg?
Smith JP; Solomon TE
Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(2):G91-G101. PubMed ID: 24177032
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice.
Smith JP; Cooper TK; McGovern CO; Gilius EL; Zhong Q; Liao J; Molinolo AA; Gutkind JS; Matters GL
Pancreas; 2014 Oct; 43(7):1050-9. PubMed ID: 25058882
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines.
Monstein HJ; Ohlsson B; Axelson J
Scand J Gastroenterol; 2001 Jul; 36(7):738-43. PubMed ID: 11444473
[TBL] [Abstract][Full Text] [Related]
4. Role of endogenous cholecystokinin on growth of human pancreatic cancer.
Matters GL; McGovern C; Harms JF; Markovic K; Anson K; Jayakumar C; Martenis M; Awad C; Smith JP
Int J Oncol; 2011 Mar; 38(3):593-601. PubMed ID: 21186400
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
6. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study.
Monstein HJ; Nylander AG; Salehi A; Chen D; Lundquist I; Håkanson R
Scand J Gastroenterol; 1996 Apr; 31(4):383-90. PubMed ID: 8726308
[TBL] [Abstract][Full Text] [Related]
10. Temporal expression of the gastrin (CCK-B) receptor during azaserine-induced pancreatic carcinogenesis.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Pancreas; 1993 Sep; 8(5):615-21. PubMed ID: 8302799
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous expression of cholecystokinin and gastrin receptor in stomach and pancreatic cancer: An immunohistochemical study.
Rai R; Kim JJ; Tewari M; Shukla HS
J Cancer Res Ther; 2016; 12(1):411-6. PubMed ID: 27072272
[TBL] [Abstract][Full Text] [Related]
12. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
[TBL] [Abstract][Full Text] [Related]
13. Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor.
Nadella S; Burks J; Al-Sabban A; Inyang G; Wang J; Tucker RD; Zamanis ME; Bukowski W; Shivapurkar N; Smith JP
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G699-G712. PubMed ID: 29927319
[TBL] [Abstract][Full Text] [Related]
14. The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Jun; 42(2):195-209. PubMed ID: 1664265
[TBL] [Abstract][Full Text] [Related]
15. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C
Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465
[TBL] [Abstract][Full Text] [Related]
16. Gastrins, cholecystokinins and gastrointestinal cancer.
Aly A; Shulkes A; Baldwin GS
Biochim Biophys Acta; 2004 Jul; 1704(1):1-10. PubMed ID: 15238241
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic function in CCK-deficient mice: adaptation to dietary protein does not require CCK.
Lacourse KA; Swanberg LJ; Gillespie PJ; Rehfeld JF; Saunders TL; Samuelson LC
Am J Physiol; 1999 May; 276(5):G1302-9. PubMed ID: 10330022
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the CCK-C (cancer) receptor in human pancreatic cancer.
Smith JP; Verderame MF; McLaughlin P; Martenis M; Ballard E; Zagon IS
Int J Mol Med; 2002 Dec; 10(6):689-94. PubMed ID: 12429993
[TBL] [Abstract][Full Text] [Related]
19. Chronic oral administration of protease inhibitor decreases CCK-A receptor mRNA expression but increases pancreatic growth in rats.
Fukumitsu K; Nakamura H; Otsuki M
Pancreas; 2001 Mar; 22(2):179-85. PubMed ID: 11249073
[TBL] [Abstract][Full Text] [Related]
20. Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma.
Goetze JP; Nielsen FC; Burcharth F; Rehfeld JF
Cancer; 2000 Jun; 88(11):2487-94. PubMed ID: 10861424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]